HAYWARD, Calif., July 18, 2013 /PRNewswire/ -- Solta Medical,
Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics
market, today announced that it will release its financial results
for the second quarter ended June 30,
2013, after market close on Tuesday,
August 6, 2013. The Company will also host a
conference call and webcast on Tuesday,
August 6, 2013, at 4:30 p.m. Eastern
Time (1:30 p.m. Pacific) to
discuss the financial results and current corporate
developments. The dial-in number for the conference call is
877-941-6009 for domestic participants and 480-629-9818 for
international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a
global leader in the medical aesthetics market providing innovative
solutions with proven efficacy and safety backed by over 10 years
of clinical study and research. The company offers aesthetic energy
devices for skin resurfacing and rejuvenation, acne reduction, body
contouring and skin tightening, as well as tools and accessories to
optimize the latest liposuction techniques. The Solta Medical
portfolio includes the well-known brands
Thermage®, Fraxel®, Clear +
Brilliant®, Liposonix®,
Isolaz®, CLARO®,
VASERlipo™, VASERshape™,
VASERsmooth™, VentX®,
PowerX®, TouchView®, and
Origins™, which collectively make up a
comprehensive platform to address a range of aesthetic skin and
body issues. More than two and a half million procedures have been
performed with Solta Medical's products around the world. Solta
Medical is headquartered in Hayward,
CA with field teams and regional offices worldwide.
SOURCE Solta Medical, Inc.